Musaffa Logo
Eastman Kodak Co KODK
$9.84 $0.15 (1.55%) 1D

Last Updated: Aug 21, 12:00 AM·NYSE

Pricing for US stocks is delayed by 24 hours

KODK Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Eastman Kodak Co is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

Eastman Kodak Co

Eastman Kodak Co. Stock Analysis KODK

United States Information Technology Small Cap

Eastman Kodak Co (KODK) Chart

Financial Metrics & Statements of Eastman Kodak Co (KODK)

FAQ's for Eastman Kodak Co (KODK)

  • As of August 2026, Eastman Kodak Co KODK is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Eastman Kodak Co using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Eastman Kodak Co if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Eastman Kodak Co by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Eastman Kodak Co may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Eastman Kodak Co on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.